US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 32.120
  • +0.640+2.03%
Close Mar 27 16:00 ET
  • 32.100
  • -0.020-0.06%
Post 17:11 ET
12.39BMarket Cap-3.46P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5800
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 19.88M
  • Tracey Franklin
  • Chief People and Digital Technology Officer
  • --
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 17.37M
  • Kate Cronin
  • Chief Brand Officer
  • --
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 17.21M
  • Dr. Jerh Collins, PhD
  • Chief Technical Operations and Quality Officer
  • --
  • Dr. Jacqueline Miller, M.D.
  • Chief Medical Officer
  • --
  • Dr. Rose Loughlin, PhD
  • Executive Vice President, Research
  • --
  • Dr. Stephen Hoge, M.D.
  • President
  • 9.18M
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 644.37K
  • Elizabeth E. Tallett
  • Independent Director
  • 578.40K
  • Paul Sagan
  • Independent Director
  • 558.40K
  • David M. Rubenstein
  • Independent Director
  • 551.61K
  • Abbas Hussain
  • Independent Director
  • 609.07K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 578.38K
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 578.40K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 578.38K

Market Insights

Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More